Lensar (LNSR) Change in Accured Expenses (2019 - 2026)
Lensar (LNSR) posted quarterly Change in Accured Expenses of -$3.9 million for Q1 2026, down 3853.4% year-over-year from $103000.0 in Q1 2025, and down 170.73% quarter-over-quarter from -$1.4 million in Q4 2025.
Lensar (LNSR) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Change in Accured Expenses for 8 consecutive years, with -$3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 3853.4% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$4.3 million (down 253.22% YoY), while the FY2025 annual figure was -$341000.0, down 127.97% from the prior year.
- Change in Accured Expenses fell to -$3.9 million in Q1 2026 per LNSR's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.2 million in Q3 2025 and bottomed at -$3.9 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged -$117647.1 across 5 years, with a median of $165000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses jumped 278.57% — and 2026, when it tumbled 3853.4%.
- Lensar's Change in Accured Expenses stood at -$266000.0 in 2022, then surged by 200.0% to $266000.0 in 2023, then surged by 278.57% to $1.0 million in 2024, then tumbled by 241.81% to -$1.4 million in 2025, then slumped by 170.73% to -$3.9 million in 2026.
- Business Quant data shows LNSR's Change in Accured Expenses at -$3.9 million in Q1 2026, -$1.4 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Lensar | 104.16 Mn | 90.59 Mn | 9.78 Mn | 823,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 823,000.00 |
| Jun 30, 2026 | 823,000.00 |
| Mar 31, 2026 | -3.87 Mn |
| Mar 31, 2026 | -3.87 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | -1.18 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | -1.49 Mn |
| Mar 31, 2024 | -1.49 Mn |